<DOC>
	<DOCNO>NCT01581502</DOCNO>
	<brief_summary>The purpose study determine choice anticoagulant therapy acute chronic stage ischemic stroke/TIA short- long-term outcome , include stroke recurrence bleeding complication , patient nonvalvular atrial fibrillation .</brief_summary>
	<brief_title>SAMURAI-NVAF Study : Anticoagulant Therapy Japanese Stroke Patients With Nonvalvular Atrial Fibrillation ( NVAF )</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Consecutive acute ischemic stroke/TIA patient NVAF 1 . Rheumatic mitral valve disease 2 . A history prosthetic valve replacement mitral valve surgical repair 3 . Active infective endocarditis 4 . Patient , family member legally responsible person give informed consent 5 . Inappropriate patient 's condition study enrollment opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>Recurrent stroke</keyword>
	<keyword>Bleeding</keyword>
</DOC>